Paper39061972
Gut-Liver-Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies.
Marroncini G and 3 others. Biomedicines, 2024. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Gut-Liver-Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies. Papers, record 39061972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39061972
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gut-Liver-Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ECS00000017 - CUP B83C22003920001. | funded by the European Union - NextGenerationEU - National Recovery and Resilience Plan, Mission 4 Component 2 - Investment 1.5 - THE - Tuscany Health Ecosystem - ECS00000017 - CUP B83C22003920001. | PubMed |
Source PubMed
References311
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34737144 | Glucagon-like peptide-1 receptor activation maintains extracellular matrix integrity by inhibiting the activity of mitogen-activated protein kinases and activator protein-1. | Free Radic Biol Med | 2021 | https://conductscience.org/library/papers/34737144 | PubMed |
| 2 | 24458110 | Short-chain fatty acid receptor and its contribution to glucagon-like peptide-1 release. | Digestion | 2014 | https://conductscience.org/library/papers/24458110 | PubMed |
| 3 | 28504618 | Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice. | Exp Biol Med (Maywood) | 2017 | https://conductscience.org/library/papers/28504618 | PubMed |
| 4 | 36979861 | From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications. | Biomedicines | 2023 | https://conductscience.org/library/papers/36979861 | PubMed |
| 5 | 11352068 | Commensal host-bacterial relationships in the gut. | Science | 2001 | https://conductscience.org/library/papers/11352068 | PubMed |
| 6 | 26023106 | GPR43 Potentiates β-Cell Function in Obesity. | Diabetes | 2015 | https://conductscience.org/library/papers/26023106 | PubMed |
| 7 | 38128856 | Effects of short-chain fatty acids on blood glucose and lipid levels in mouse models of diabetes mellitus: A systematic review and network meta-analysis. | Pharmacol Res | 2024 | https://conductscience.org/library/papers/38128856 | PubMed |
| 8 | 19360006 | Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. | Obesity (Silver Spring) | 2009 | https://conductscience.org/library/papers/19360006 | PubMed |
| 9 | 23146568 | Short chain fatty acids and their receptors: new metabolic targets. | Transl Res | 2013 | https://conductscience.org/library/papers/23146568 | PubMed |
| 10 | 29567829 | The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. | Cancer Discov | 2018 | https://conductscience.org/library/papers/29567829 | PubMed |
| 11 | 29798856 | Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. | Science | 2018 | https://conductscience.org/library/papers/29798856 | PubMed |
| 12 | 36195972 | Bifidobacterium spp. and their metabolite lactate protect against acute pancreatitis via inhibition of pancreatic and systemic inflammatory responses. | Gut Microbes | 2022 | https://conductscience.org/library/papers/36195972 | PubMed |
| 13 | 22173168 | The interaction of hepatic lipid and glucose metabolism in liver diseases. | J Hepatol | 2012 | https://conductscience.org/library/papers/22173168 | PubMed |
| 14 | 23665276 | Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. | Gastroenterology | 2013 | https://conductscience.org/library/papers/23665276 | PubMed |
| 15 | 35402293 | Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/35402293 | PubMed |
| 16 | 28811235 | Sodium butyrate ameliorates S100/FCA-induced autoimmune hepatitis through regulation of intestinal tight junction and toll-like receptor 4 signaling pathway. | Immunol Lett | 2017 | https://conductscience.org/library/papers/28811235 | PubMed |
| 17 | 31398337 | Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. | Cell | 2019 | https://conductscience.org/library/papers/31398337 | PubMed |
| 18 | 38213140 | Investigating the Influence of Gut Microbiota-related Metabolites in Gastrointestinal Cancer. | Curr Cancer Drug Targets | 2024 | https://conductscience.org/library/papers/38213140 | PubMed |
| 19 | 21364590 | Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion. | Br J Cancer | 2011 | https://conductscience.org/library/papers/21364590 | PubMed |
| 20 | 30300287 | Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH. | Transplantation | 2019 | https://conductscience.org/library/papers/30300287 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42891339 | Microbiome-pancreatic cancer crosstalk: From tumor biology to therapeutic intervention. | IMetaOmics | 2026 | https://conductscience.org/library/papers/42891339 | PubMed |
| 42724341 | Metabolic reprogramming in diabetes and cancer: the role of PI3K/AKT/mTOR and beyond. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/42724341 | PubMed |
| 42626202 | Pancreatic-liver crosstalk, novel molecular mediators, and 2025 therapeutic breakthroughs. | World J Methodol | 2026 | https://conductscience.org/library/papers/42626202 | PubMed |
| 42387035 | Tirzepatide as a multi-organ integrator in metabolic diseases: a review of molecular mechanisms and clinical translation. | Endocrine | 2026 | https://conductscience.org/library/papers/42387035 | PubMed |
| 42346379 | Nervonic Acid Prevents HFD-Induced Metabolic Dysfunction and Is Associated with Gut Microbiota Remodeling. | Metabolites | 2026 | https://conductscience.org/library/papers/42346379 | PubMed |
| 42278319 | The Gut-Pancreas Axis in Type 1 Diabetes: Emerging Insights into Microbiota and Immune Interactions. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278319 | PubMed |
| 42267834 | Gut microbiota-derived short-chain fatty acids (SCFAs): immunomodulatory effects and therapeutic potential in infections. | Clin Microbiol Rev | 2026 | https://conductscience.org/library/papers/42267834 | PubMed |
| 42190476 | Spatiotemporal screening and functional analysis of gut microbiota associated with abdominal fat deposition in breeder broiler hens. | Poult Sci | 2026 | https://conductscience.org/library/papers/42190476 | PubMed |
| 42072734 | Emerging Insights into the Liver-Pancreas Axis: A Central Hub in the Pathogenesis of Diabetes and Metabolic Diseases. | Biomolecules | 2026 | https://conductscience.org/library/papers/42072734 | PubMed |
| 42051491 | Loss of immunometabolic adaptability in MASH: gut-derived signals drive macrophage reprogramming and fibrosis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42051491 | PubMed |
| 42046235 | Persistently elevated serum gamma-glutamyl transferase is associated with pancreatic cyst development: A sex-stratified propensity score matched multicenter cohort study. | Ann Hepatobiliary Pancreat Surg | 2026 | https://conductscience.org/library/papers/42046235 | PubMed |
| 41970986 | Escherichia-Shigella expansion and metabolite dysregulation in type 3c diabetes: linking microbiome alterations to exocrine pancreatic insufficiency. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41970986 | PubMed |
| 41783801 | The role of bile acid-activated receptor TGR5 in inflammation and liver diseases. | Front Physiol | 2026 | https://conductscience.org/library/papers/41783801 | PubMed |
| 41669928 | Evaluation of Pancreatic Steatosis in Patients with Celiac Disease. | Turk J Gastroenterol | 2025 | https://conductscience.org/library/papers/41669928 | PubMed |
| 41601885 | Hyperoside ameliorates NAFLD in rats via remodeling gut microbiota and reprogramming serum metabolic networks. | Front Nutr | 2025 | https://conductscience.org/library/papers/41601885 | PubMed |
| 41584842 | β-cell heterogeneity and molecular plasticity in type 2 diabetes: multi-omics perspectives and the role of gut microbiota. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/41584842 | PubMed |
| 41578068 | Global Trends in Bariatric Surgery for the Treatment of Metabolic Syndrome: A Bibliometric and Visualization Analysis. | Obes Surg | 2026 | https://conductscience.org/library/papers/41578068 | PubMed |
| 41459531 | Targeting the TLR4 axis with microbiota-oriented interventions and innovations in diabetes therapy: a narrative review. | Front Immunol | 2025 | https://conductscience.org/library/papers/41459531 | PubMed |
| 41452512 | Therapeutic Potential and Functional Mechanisms of Probiotics as Prospective anti-inflammatory Agents. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/41452512 | PubMed |
| 41440201 | Important Role of Bacterial Metabolites in Development and Adjuvant Therapy for Hepatocellular Carcinoma. | Curr Oncol | 2025 | https://conductscience.org/library/papers/41440201 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GCG | 2641 | PubTator's text mining | https://conductscience.org/library/genes/2641 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39061972
GET https://conductscience.org/api/papers/v1/39061972/references?page=2